Company / CapEx per Share
Perspective Therapeutics, Inc. CapEx per Share History
FY2013-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.00
FY2022
5-year range
$0.00 / $0.01
FY2018-FY2022
Trend
-70.9%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
CapEx per Share has fluctuated over the past 10 years, ranging from $0.00 in FY2015 to $0.01 in FY2019.
Based on SEC 10-K filings.
0.00 in FY2022 with a 5-year CAGR of -5.0%.
Declined from $0.01 to $0.00 over the past 2 years.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -42.3%
- 5-Year CAGR
- -5.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2022, capex per share decreased 70.9% year-over-year.
- Peak capex per share was recorded in FY2019.
- Lowest capex per share in the period was in FY2015.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 5.43 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | $0.00 | -70.9% |
| FY2021 | $0.01 | +28.9% |
| FY2020 | $0.01 | -48.7% |
| FY2019 | $0.01 | +11.9% |
| FY2018 | $0.01 | +260.1% |
| FY2017 | $0.00 | +427.8% |
| FY2016 | $0.00 | +189.4% |
| FY2015 | $0.00 | -16.7% |
| FY2014 | $0.00 | -89.3% |
| FY2013 | $0.00 | - |
As of FY2022 · SEC 10-K · Updated Jun 24, 2026